Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 28 Melanoma 25 Carcinoma, Renal Cell 22 Lung Neoplasms 11 Neoplasm Metastasis 10 Squamous Cell Carcinoma of Head and Neck 9 Neoplasms 9 Colorectal Neoplasms 9 Prostatic Neoplasms 8 Hodgkin Disease 8 Carcinoma, Transitional Cell 7 Carcinoma, Hepatocellular 7 Adenocarcinoma Of Esophagus 7 Triple Negative Breast Neoplasms 6 Stomach Neoplasms 6 Rectal Neoplasms 6 Ovarian Neoplasms 6 Pancreatic Neoplasms 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Nasopharyngeal Carcinoma 4 Multiple Myeloma 4 Endometrial Neoplasms 4 Carcinoma, Merkel Cell 4 Carcinoma, Basal Cell 4 Brain Neoplasms 4 Anus Neoplasms 4 Thyroid Neoplasms 3 Sarcoma, Kaposi 3 Recurrence 3

Interventions

Vinblastine 1 Nivolumab 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Childhood Solid Tumor × Nivolumab × 30 days × Clear all

NCT03585465 2026-05-29

Metro-PD1

Centre Oscar Lambret

Phase 1/2 Terminated

Other solid neoplasm

Childhood Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡